Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Final FDA Quality Agreements Guidance Retains Focus On Commercial Manufacturing

Executive Summary

Final US FDA guidance on contract manufacturing quality agreements retains draft version’s focus on commercial activities even though industry asked for it to also cover arrangements between manufacturers and contract partners developing investigational drugs.


Related Content

Pfizer Contract Manufacturer Slammed By US FDA For Dissolution Failures And Leaking Bottles
FDA, EU To Redouble Inspection Of Asian Pharmaceutical Supply Chains
FDA Details “Quality Agreements” For Marketers, Contract Manufacturers





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts